Literature DB >> 28585370

Gout: an Asia-Pacific update.

Binoy J Paul1, Reeta James1.   

Abstract

Even though, Hippocrates recognized gout as an affection of older men and a product of high living long back in 5th century BC, this painful condition promises to accompany humanity to the 21st century. The incidence is progressively rising and females are also affected in the modern era. There are also regional and ethnic variations in the incidence, the genetics of which is being studied. The recommended best therapy for the acute attacks and long term prophylaxis has improved remarkably in the recent years. However, patients are often treated inadequately and risk factors for their disease are not well explored in daily practice. Although well designed long term studies of current and newer treatment are welcomed, educating doctors especially the primary care physicians who manage majority of gout cases, in optimizing the currently available management options would improve the present care.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  disease aetiology and pathogenesis - human; gout; metabolic and crystal arthropathies drug treatment; metabolic and crystal arthropathies epidemiology; metabolic and crystal arthropathies inflammasome

Mesh:

Substances:

Year:  2017        PMID: 28585370     DOI: 10.1111/1756-185X.13103

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

1.  Insights in Public Health: Hyperuricemia and Gout in Hawai'i.

Authors:  Mika D Thompson
Journal:  Hawaii J Med Public Health       Date:  2018-05

2.  Xanthine Oxidase Inhibitory Activity, Chemical Composition, Antioxidant Properties and GC-MS Analysis of Keladi Candik (Alocasia longiloba Miq).

Authors:  Ferid Abdulhafiz; Arifullah Mohammed; Fatimah Kayat; Matcha Bhaskar; Zulhazman Hamzah; Sanjay Kumar Podapati; Lebaka Veeranjaneya Reddy
Journal:  Molecules       Date:  2020-06-08       Impact factor: 4.411

3.  Trends in hospital visits and healthcare costs of gout and seropositive rheumatoid arthritis in Korea from 2010 to 2017 using National Healthcare Claims.

Authors:  Kyeong Min Son; Ju-Ryoung Kim; Hang A Park; Hyun Ah Kim
Journal:  Korean J Intern Med       Date:  2021-10-26       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.